Europe PMC
open access
Serum proteomic profiling identifies transforming growth factor β receptor as a marker of persistent symptoms up to 18 months after mild SARS-CoV-2 infection
Persistent symptoms following the acute phase of SARS-CoV-2 infection have emerged as an increasing health problem. The pathogenesis for the development of post-COVID Condition (PCC) is still elusive. Herein we included serum samples from non-hospitalized (n = 189) and hospitalized (n = 52) COVID-19
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Record · ID 1614455
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive